Abcuro
PrivateLast Round
Series C
2/12/2025
Total Funding Raised
$407.3M
Company Overview
Abcuro is a biopharmaceutical company that develops immunomodulatory therapeutics aimed at treating autoimmunity and cancer through innovative analysis of transcription data to target critical immune system components.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abcuro Comps
Public and private peers based on sector, stage, and business model.
Abcuro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | 2/12/2025 | ||||
| Series B | 8/17/2023 | ||||
| Series A Extension | 1/7/2021 | ||||
| Series A | 11/20/2018 | ||||
| Seed | 12/13/2016 |
Key People
Founding team and executive leadership
Abcuro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Redmile Group | Series C, Series B |
| Soleus Capital | Series C, Series B |
| Bain Capital Life Sciences | Series C, Series B |
| RA Capital Management | Series C, Series A Extension, Series B |
| New Leaf Venture Partners | Series C, Series B |
| New Enterprise Associates (NEA) | Series C |
| Kaitai Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 18, 2025
George Eldridge appointed as new CFO.
- Jun 9, 2025
Courtney Cupples appointed as Chief Commercial Officer.
Abcuro Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abcuro's valuation, stock price, and market status.
